Company / Capital Expenditures
Bio-Rad Laboratories Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$157.6M
FY2025
5-year range
$112.8M / $165.6M
FY2021-FY2025
Trend
-4.8%
vs FY2024
Sector context
#47 of 151
Health Care
What the data says
At $158M, Bio-Rad Laboratories's capital expenditures ranks #47 of 151 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $99M in FY2019 to $166M in FY2024.
Based on SEC 10-K filings.
$158M in FY2025 with a 5-year CAGR of +4.0%.
Remained stable around $158M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +11.8%
- 5-Year CAGR
- +4.0%
- 10-Year CAGR
- -
Sector benchmark
#47 of 151 in Health CareTop 31% of 151This company $157.6M Sector average $271.7M
▼
-42.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.0%, indicating consistent growth.
- In FY2025, capital expenditures decreased 4.8% year-over-year.
- Ranks #47 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $157.6M | -4.8% |
| FY2024 | $165.6M | +5.7% |
| FY2023 | $156.7M | +38.9% |
| FY2022 | $112.8M | -15.7% |
| FY2021 | $133.7M | +3.0% |
| FY2020 | $129.8M | +31.8% |
| FY2019 | $98.5M | -30.3% |
| FY2018 | $141.4M | +26.3% |
| FY2017 | $112.0M | -7.4% |
| FY2016 | $121.0M | +8.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026